Met-Tara Injection 100 ml

Met-Tara Injection belongs to a group of medicines known as antibacterial agents used to treat severe bacterial infections of the bone, skin and skin structure, blood, joint, abdomen, central nervous system, respiratory, and gynaecological systems, meningitis (infection of the membranes that surround the brain and spinal cord), and endocarditis (infection of the heart lining and valves). 

Met-Tara Injection contains Metronidazole, which suppresses protein synthesis by interacting with DNA and causing helical DNA structure loss and strand breakage. As a result, it induces cell death in susceptible organisms. Thus, Met-Tara Injection treats bacterial infections.

Met-Tara Injection will be administered by a healthcare professional; do not self-administer. Some common side effects of Met-Tara Injection are nausea, vomiting, diarrhoea, constipation, and injection site reaction. These side effects are temporary and may resolve after some time. However, if any of the side effects persist or worsen, contact the doctor.

Let your doctor know if you are allergic to metronidazole. Consult your doctor if you are pregnant, planning to get pregnant, or if you are breastfeeding. Do not operate heavy machinery or drive after taking Met-Tara Injection as it may cause dizziness and drowsiness. Avoid consumption of alcohol while on treatment with Met-Tara Injection as it may cause unpleasant side effects.

Met-Tara Injection used in the treatment of bacterial infections. The detailed uses of Met-Tara Injection are as follows:

• Treatment of Infections: Met-Tara Injection effectively treats various infections, including intra-abdominal, skin, gynecologic, septicemia, bone and joint, CNS, respiratory tract, and endocarditis, by eliminating anaerobic bacteria and parasites, stopping their growth, and alleviating symptoms.
• Surgical Prophylaxis: Met-Tara Injection is used as a surgical prophylaxis to prevent postoperative infections, particularly for surgeries involving the gastrointestinal tract.
• Management of Clostridium Difficile Infection: Met-Tara Injection is used to manage severe Clostridium difficile infections, especially when oral medication is not possible.
• Amoebic Dysentery Treatment: Met-Tara Injection is used to treat amoebic dysentery, a severe intestinal infection caused by the Entamoeba histolytica parasite.
• Combination Therapy: Met-Tara Injection is often used in combination with other antibiotics to treat serious infections, offering a broad spectrum of action and enhancing treatment effectiveness.

• Follow your doctor’s instructions on the dosage and timing of this medication to ensure safe and effective use.
• Met-Tara Injection will be administered by the doctor or healthcare professional.
• Do not self-administer.

Met-Tara Injection belongs to a group of medicines known as anti-bacterial agents used to treat severe bacterial infections of the bone, skin and skin structure, blood, joint, abdomen, central nervous system, gynecologic, respiratory infections, meningitis (infection of the membranes that surround the brain and spinal cord), and endocarditis (infection of the heart lining and valves). Met-Tara Injection contains Metronidazole, which suppresses protein synthesis by interacting with DNA and causes helical DNA structure loss and strand breakage. As a result, it induces cell death in susceptible organisms. Thereby, Met-Tara Injection treats bacterial infections.

Do not take Met-Tara Injection if you are allergic to any of the components. Consult your doctor if you are pregnant, plan to get pregnant or if you are breastfeeding. Do not operate heavy machinery or drive after taking Met-Tara Injection as it may cause dizziness and drowsiness. Inform your doctor if you have bone marrow depression/low blood count, kidney impairment, CNS disorder, liver or heart problems, peripheral neuropathy, epilepsy, Crohn's disease (a condition in which the body attacks the lining of the digestive tract), yeast infection, oedema (swelling), or blood disorders.